This study aimed to implement quorum quenching (QQ) to mitigate membrane fouling in membrane bioreactors (MBRs) treating phenol-rich pharmaceutical wastewater using Rhodococcus sp. BH4 and isolated QQ consortium (QQcs) from activated sludge. Neither BH4 nor QQcs impacted the removal efficiency of chemical oxygen demand (COD) (>94%), phenol (>99%), and ammonium (>99%), indicating that QQ did not have adverse impact on treatment performance. In addition, both BH4 and QQcs effectively retarded membrane fouling, which could be attributed to the reduction of soluble microbial products (SMP). Interestingly, the TMP increase was delayed 68.7% by Rhodococcus sp. BH4, while 31.3% was achieved by QQcs. This difference may be due to the relatively higher degradation for short- and medium-chain N-acyl-homoserine lactones (AHLs) by BH4 compared to the QQcs. Furthermore, the possible presence of quorum sensing (QS) bacteria within QQcs also could have contributed to the less effective fouling control than that of BH4.
Keywords: Membrane bioreactors; N-acyl-L-homoserine lactones; Phenol-rich wastewater; Quorum quenching consortium; Rhodococcus sp. BH4.
Copyright © 2022 Elsevier Ltd. All rights reserved.